PSA, everyone should be getting the HPV vaccine, regardless of age and gender. https://en.wikipedia.org/wiki/HPV_vaccine https://www.mdanderson.org/publications/focused-on-health/wh... https://www.cdc.gov/cancer/hpv/oropharyngeal-cancer.html
Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
31–40 of 100 posts
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#32PSA, everyone should be getting the HPV vaccine, regardless of age and gender. https://en.wikipedia.org/wiki/HPV_vaccine https://www.mdanderson.org/publications/focused-on-health/wh... https://www.cdc.gov/cancer/hpv/oropharyngeal-cancer.html
> PSA, everyone should be getting the HPV vaccine, regardless of age and gender. This is false, please don't take medical advice from an HN post. CDC guidelines do include quite a bit of discussion of patient age. [1] 1. https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.htm...
The reason many people don't trust the CDC's advice is they don't really tell you why or why not.
If you're over 26 you're pretty likely to already be exposed to HPV but not necessarily every strain which would be protected by the vaccine (as it says in the article).
So this pushes the question: why shouldn't I get it even if there's only a small chance it will be beneficial at my age? Is there really a risk they're not telling me about or are they giving bullshit answers? There isn't a third direction.
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#33PSA, everyone should be getting the HPV vaccine, regardless of age and gender. https://en.wikipedia.org/wiki/HPV_vaccine https://www.mdanderson.org/publications/focused-on-health/wh... https://www.cdc.gov/cancer/hpv/oropharyngeal-cancer.html
Annoyed at how the guidance has changed on this over the years. At first it was just a narrow slice of 20 something women. Then girl teenagers. Then men and women under 30. Then under 40. If it has an association with preventing cancers, not sure why they were so reluctant to immediately open up the patient pool.
This defuses the "Should I kill one to save ten?" moral dilemma - the individual is your patient, even if the other ten are also your patients, you must not harm the one. But for vaccines it also means that the wider societal implications are not ethically relevant
So, medics won't recommend that you give patient A an intervention which is of no benefit to A but is really helpful for everybody else. For example, that you vaccinate teenage boys in the expectation that this way they won't infect teenage girls (with whom statistically many of them will have sex) with an STI that harms those girls.
As a result, the guidance cared about proven benefits to you even though taken neutrally you might have been enthusiastic about a vaccine that might or might not protect you but is definitely a good idea for the wider population. The initial studies understandably focused on the numerically larger problem: If we vaccine young female patients does that prevent relevant HPV infections, and then, as a proxy we might assume they also won't get cancer. Such studies can't tell you whether it prevents men getting cancer because that wasn't measured.
So the recommendation to vaccinate boys was delayed because first somebody has to study what might seem obvious - does the vaccine also prevent HPV related cancers in males? It is, after all, possible that some subtle mechanism means the vaccine isn't effective for this purpose, and it would not be ethical to give schools full of boys a vaccine that they personally do not benefit from having - even if societally maybe that's a good choice.
Beyond the female/ male differential, for adults and older, it's basically a stats game. Most adults have sex. Having sex means you're likely to contract HPV, more sex, more exposure. Is it worth getting vaccinated when there's a 50% chance it's useless? How about 95%? 99.5%? Do you always wait for the crossing lights? Did you ever drink beer or eat bacon ?
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#34PSA, everyone should be getting the HPV vaccine, regardless of age and gender. https://en.wikipedia.org/wiki/HPV_vaccine https://www.mdanderson.org/publications/focused-on-health/wh... https://www.cdc.gov/cancer/hpv/oropharyngeal-cancer.html
> PSA, everyone should be getting the HPV vaccine, regardless of age and gender. This is false, please don't take medical advice from an HN post. CDC guidelines do include quite a bit of discussion of patient age. [1] 1. https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.htm...
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#35Any idea why they used a dog (or werewolf?) mouth model in the video?
It seems to just be a single line of each type of tooth.. but it does look dog like in profile.
https://www.cell.com/cms/10.1016/j.ymthe.2024.12.008/asset/b...
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#36Any idea why they used a dog (or werewolf?) mouth model in the video?
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#37Earlier quoted context omitted.
Annoyed at how the guidance has changed on this over the years. At first it was just a narrow slice of 20 something women. Then girl teenagers. Then men and women under 30. Then under 40. If it has an association with preventing cancers, not sure why they were so reluctant to immediately open up the patient pool.
This is how science works. Our understanding of a medication's efficacy evolves over time.
It is either A) underreporting risks or B) not acknowledging risk unknowns and plowing ahead with advice anyway.
This was the major problem and behavior that CAUSED anti-vax opinions. They made safety claims that they couldn't logically make, because they couldn't know. A new vaccine using a new vaccine technology vs a new virus. They did not correctly report the amount of uncertainty and they lost trust. Then folks who "knew better" did their best to manipulate the narriative.
And speaking of manipulating the narrative, you can't use google to find the bits of history that shows the CDC giving contradictory advice because the results aren't there any more. Nearly every result gives the same tone and they're almost all CDC links.
This kind of information control and lack of transparency isn't science, it's power dictating truth.
The actual truth is that the risk of cancers as a result of HPV have a pretty high chance of being prevented if young females get the vaccine, but as you get further away from that group the risk avoided by getting vaccinated gets progressively smaller and runs into the safety uncertainty of taking the vaccine. When you're doing population level risk management you also have to do things like comparing the risk of getting hit by a bus going to the clinic against whatever the clinic could do for you. It is often safer to do nothing than to avoid a very tiny risk because of the very mundane risks you face day to day.
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#38Earlier quoted context omitted.
> I think their Epic Health computer system that needs me to confirm my date of birth every 6 weeks can find some time to suggest the HPV vaccine if it is so damn medically necessary. You're assuming that the purpose of the EHR (Epic) is to implement public health recommendations or to establish minimum standards of care. That's a reasonable assumption for someone who doesn't work in the field, but unfortunately it's…
What are? Let me make a cynical guess: 1. Reducing costs by hiring fewer people. 2. Increasing profits by decreasing care. Did I nail it or what?
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#39Earlier quoted context omitted.
Annoyed at how the guidance has changed on this over the years. At first it was just a narrow slice of 20 something women. Then girl teenagers. Then men and women under 30. Then under 40. If it has an association with preventing cancers, not sure why they were so reluctant to immediately open up the patient pool.
Medical ethics focus on the benefit to a specific individual - your patient. This defuses the "Should I kill one to save ten?" moral dilemma - the individual is your patient, even if the other ten are also your patients, you must not harm the one. But for vaccines it also means that the wider societal implications are not ethically relevant So, medics won't recommend that you give patient A an intervention which is o…
Back when the vaccine was new, an objection from some parents was that the vaccine might be viewed as a license or permission for their daughters to be promiscuous. There was a substantial headwind.
The public wasn't yet generally aware that HPV could cause head, neck, and anal cancers in men. If a doctor approached a parent back in 2010 and said they wanted to vaccinate their son against head, neck, and anal cancer, that advice wouldn't have been heeded in many cases, and would have cost the CDC some amount of its standing with the public.
When you hear something from the CDC, there's a decent possibility that it's a blend of medical advice that's been compromised with some value judgements that haven't been expressed to the listener.
Re: Antiviral chewing gum to reduce influenza and herpes simplex virus transmission
#40Earlier quoted context omitted.
> PSA, everyone should be getting the HPV vaccine, regardless of age and gender. This is false, please don't take medical advice from an HN post. CDC guidelines do include quite a bit of discussion of patient age. [1] 1. https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.htm...
Either the vaccine has notable safety issues or it should be at least fine to get the vaccine at an older age. The reason many people don't trust the CDC's advice is they don't really tell you why or why not. If you're over 26 you're pretty likely to already be exposed to HPV but not necessarily every strain which would be protected by the vaccine (as it says in the article). So this pushes the question: why shouldn'…
> Compared with the benefit of the existing HPV vaccination program for adolescents and young adults through age 26 years, the additional benefit of vaccinating people age 27 through 45 years would be minimal.
> Given abundant evidence for safety of HPV vaccines, undesirable anticipated effects are minimal. Also, anticipated population-level benefits are minimal for vaccinating adults over age 26 years. In this scenario, other considerations including cost-effectiveness play an important role in guiding policy-making.
https://www.cdc.gov/acip/evidence-to-recommendations/HPV-adu...
Elsewhere:
> There’s not a safety issue past age 45. We just aren’t sure how much the vaccine will help men and women who are past that age, because so many of us have acquired HPV by that point, and because it takes many years for cancer to develop after acquiring the virus. However, as the average life expectancy increases, it may benefit the population to increase the age limit for HPV vaccination as well.
https://www.mskcc.org/news/think-you-re-too-old-get-hpv-vacc...